Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.28 - $2.4 $190,214 - $356,652
-148,605 Reduced 79.84%
37,519 $64,000
Q1 2022

May 16, 2022

SELL
$2.19 - $6.09 $264,488 - $735,495
-120,771 Reduced 39.35%
186,124 $408,000
Q4 2021

Feb 14, 2022

BUY
$5.81 - $14.39 $1.65 Million - $4.1 Million
284,666 Added 1280.61%
306,895 $1.87 Million
Q3 2021

Nov 15, 2021

BUY
$11.55 - $20.3 $256,744 - $451,248
22,229 New
22,229 $308,000
Q1 2021

May 17, 2021

SELL
$13.71 - $30.64 $1.06 Million - $2.37 Million
-77,211 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$9.31 - $14.0 $31,858 - $47,908
3,422 Added 4.64%
77,211 $1.08 Million
Q3 2020

Nov 16, 2020

BUY
$9.1 - $15.81 $671,479 - $1.17 Million
73,789 New
73,789 $881,000

Others Institutions Holding GTH

# of Institutions
1
Shares Held
7.5K
Call Options Held
0
Put Options Held
0

About Genetron Holdings Ltd


  • Ticker GTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 90,602,304
  • Description
  • Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...
More about GTH
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.